Likewise, upregulation of KDM5B in HCC demethylates the H3K4me3 promoter mark and downregulates the CDKN2B and CDKN1B genes, thereby reducing the expression of p15 and p27 proteins and leading to unchecked HCC proliferation [68]. Here, CDKN2B is linked to hepatocellular carcinoma.